Tofacitinib Leads to Improvement in Itch, Other Symptoms Among Psoriasis Patients with PsA

These data on the success of twice-daily, 5 and 10 mg doses of tofacitinib may help inform clinicians in their practice as well as the health community in general.

Related Keywords

Paris ,France General ,France , ,International Psoriasis Council Herv ,International Psoriasis Council ,Itch Severity Item ,Psoriasis Area ,Severity Index ,Hospital Anxiety ,Depression Scale ,Psoriasis ,Psoriatic Arthritis ,Psa ,Pso ,Tofacitinib ,